Video

Digital Economy: The digitisation of healthcare w/ Jackie Hunter

What unique challenges surround the application of digital technologies in healthcare and how do we overcome them?

In this latest Digital Economy podcast from The Economist, Intelligence Unit host Pete Swabey discusses these challenges with Prof. Jackie Hunter, CE Clinical and Strategic Partnerships at BenevolentAI, Professor Ann Blandford, deputy director for digital health at the UCL Institute of Healthcare Engineering and Elizabeth Sukkar, Managing Editor and Global Editorial lead for healthcare at The EIU.

There are arguably few applications of digital technology more worthwhile than human health, however integrating technologies into healthcare systems is uniquely complex. This podcast provides an introduction to some of the challenges that healthcare providers face in their pursuit of digital innovation, and explores some of the paths forward. This episode touches upon issues ranging from health literacy, to the sensitivity of health data and the need for trust and transparency.

More Posts

You Might Also Like

News
BenevolentAI Announces Board Changes
BenevolentAI today announces the appointment of Dr. Susan Liautaud as a member of the board of directors of the Company with effect from 30 June 2022. Dr. Susan Liautaud will act as Independent Non-Executive Director of the Company.
May 25, 2022
News
BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
AstraZeneca selects another novel target for idiopathic pulmonary fibrosis from the collaboration for its drug development portfolio.
May 17, 2022
Blog
FDA converts emergency approval of baricitinib — first identified as a COVID treatment by BenevolentAI — to a full approval
The FDA has converted its emergency approval of baricitinib to a full approval, underscoring the strength of BenevolentAI’s AI-derived hypothesis.
May 12, 2022
News
BenevolentAI Begins Trading On Euronext Amsterdam
BenevolentAI, a leading, clinical-stage AI-enabled drug discovery company, announces that trading in its shares is expected to begin today, following completion of its business combination with Odyssey Acquisition S.A. on 22 April 2022.
Apr 25, 2022
Video
BenevolentAI · AI-Enabled Drug Discovery
Advanced technologies, combined with an exponential increase in biomedical data and research, provide an unparalleled opportunity to unravel the mysteries of diseases that have gone untreated for too long.
Apr 25, 2022
News
BenevolentAI joins the World Economic Forum’s Global Innovators Community
BenevolentAI joins the World Economic Forum’s Global Innovators Community to help ethically deploy AI to create a more sustainable, inclusive and resilient world.
Apr 21, 2022